Abstract Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the gastrointestinal tract, but are rare in the appendix with only 14 cases reported. Here we report an additional case in the oldest patient to date and review the histologic, immunohistochemical, molecular and clinical findings.
Introduction
Gastrointestinal stromal tumors (GISTs) of the appendix are rare. The Armed Forces Institute of Pathology (AFIP) has only 4 cases on file over a 28-year period [1] . Three cases were reported by Agaimy et al., in two studies [2, 3] . Single cases have been reported by Kim et al. [4] , Yap et al. [5] , Rahimi et al. [6] , Chung et al. [7] , Tran et al. [8] , Bouassida et al. [9] , and a single malignant GIST of the appendix was reported by Elazary et al. [10] GISTs are the most common mesenchymal tumor of the gastrointestinal tract. They most commonly occur in the stomach and small intestine, less frequently in the large intestine and only rarely in other gastrointestinal sites [11, 12] . Histologically, the tumor cells are spindle-shaped to epithelioid. Grading schemes have been proposed to categorize the tumors into risk groups based on mitotic activity and size [13] . Immunohistochemically, the cells characteristically express CD117 (c-kit) in up to 95% of cases [14] . The intermediate filament protein nestin is expressed in 90-100% of cases [15] . More recently described antibodies DOG-1 (discovered on GIST) and protein kinase C-theta are detected in the majority of CD117-negative cases [16, 17] . The cells typically express CD34, while expression of s-100 antigen is variable and smooth muscle actin (SMA) is typically negative [13] . Molecular studies have shown evidence of activating mutations in the c-kit and platelet-derived growth factor (PDGFR) genes in the majority of cases [18, 19] . Imatinib and other KIT tyrosine kinase inhibitors have been used in the treatment of GISTs with great success, making GISTs a model for molecular targeted therapies [20] . Subsets of GISTs are resistant to tyrosine kinase inhibitor therapies either due to the nature of the c-kit and PDGFR mutations at the drug binding sites, or due to additional acquired mutations and tumor progression [21, 22] . Additional tumor-driving mutations are being discovered that may prove to be useful targets for combination and second-line therapies such as insulin-like growth factor receptor [23, 24] .
Case report
An 88-year-old female presented to the emergency department complaining of hematochezia for several months with palpitations and lightheadedness over the last several days. Her past medical history was significant for hypertension, diverticulosis and lower GI bleeding. Her abdomen was soft, non-tender with active bowel sounds in all quadrants. She underwent subtotal colectomy for recurrent diverticular bleeding. She returned to hospital after 2 weeks with signs of dehydration, but her post-operative course has been otherwise unremarkable after 48 months of follow-up.
A right hemicolectomy including the appendix was performed. The colon contained multiple diverticula throughout the length of the specimen. The appendix was thickened near the tip. Histology of the thickened area showed a 0.5 cm proliferation of bland spindle cells in fascicles within the muscularis propria entrapping smooth muscle and ganglion cells ( Figs. 1 and 2 ). The lesion extended focally to the serosa, but did not penetrate it. Mitotic figures were rare (b 1/50 HPF). Immunohistochemical staining revealed spindle cells to be positive for CD117 (C-KIT), nestin and S-100, but negative for smooth muscle actin (SMA), synaptophysin and chromogranin (Figs. 3-6 ).
Discussion
Gastrointestinal stromal tumors of the appendix are rare, with 15 reported in the literature (including the presently reported case). The clinical and pathological features of the previous and currently reported tumors are summarized in Location within the appendix has included the tip (4 cases), mid appendix (5 cases) and the proximal appendix (4 cases). Only 1 case has behaved in a malignant fashion (the largest) and this case had aggressive microscopic features (9 mitoses per high power field and cellular atypia). The remaining cases have had very low mitotic activity when reported, and have behaved in a benign fashion in the available follow-up. All cases have had mostly spindle morphology, with 2 cases having focal epithelioid morphology, one of which also had an associated lymphoid infiltrate. The presenting symptoms were appendicitis-like in 8 cases, hematochezia in 2 cases, the tumor was incidentally found during surgery or at autopsy in the remaining cases. Of cases with reported immunohistochemical profiles, 12/13 expressed c-kit (92%), 4/14 were S-100 positive (29%), 11/11 expressed CD34 (100%), and 0/11 were positive for smooth muscle actin. Five of the reported cases (38%) occurred in patients with a history of other malignancy including mantle cell lymphoma, lung adenocarcinoma, endometrial carcinoma, bladder carcinoma and malignant gastric GIST. The association of GISTs with other malignancies has been previously noted [25, 26] . Of the 4 cases with molecular studies reported, 2 had wild type c-kit and PDGFR, and two had mutations of exon 11 of c-kit including one missense and one in frame deletion. In summary, GISTs of the appendix occur at a low rate and do have malignant potential as in other sites. As additional therapies become available, molecular studies of GISTs at all sites may be useful to personalize treatment.
